Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 317

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 317
---
:--|
| Chris Posner     | ​ | ​ | ​                                               | ​ | 4,041 | ​ | ​ | ​ | ​                                          | ​ | 5.29 | ​ | ​ | ​ | ​     | $ | 21,376.89 | ​ | ​ |
| Ryan Maynard     | ​ | ​ | ​                                               | ​ |     0 | ​ | ​ | ​ | ​                                          | ​ | 5.29 | ​ | ​ | ​ | ​     | $ |         0 | ​ | ​ |
| Scott Terrillion | ​ | ​ | ​                                               | ​ |   555 | ​ | ​ | ​ | ​                                          | ​ | 5.29 | ​ | ​ | ​ | ​     | $ |  2,935.95 | ​ | ​ |

These amounts are single-trigger payments. (3) Amount represents the payment for accrued vacation and reimbursement of COBRA premiums for health benefit coverage in an amount equal to the monthly employer contribution that Cara would have made to provide health insurance to Mr. Posner, Mr. Maynard and Mr. Terrillion had the executive remained employed with Cara until 12 months following the date of termination, based on the costs of coverage and benefit elections in effect as of January 15, 2025. This amount represents 18 months of benefits allowance for Mr. Posner and 12 months of benefits allowance for Mr. Maynard and Mr. Terrillion, respectively. Such amounts are double-trigger payments. Cara Options As of January 15, 2025, Cara’s executive officers and directors collectively held unvested stock options to purchase 155,299 shares of Cara common stock and vested stock options to purchase 151,943 shares of Cara common stock, for a total of options to purchase 307,242 shares of Cara common stock. The Cara Board has taken action to accelerate in full, effective upon consummation of the Merger, the vesting of all Cara options then outstanding. All outstanding and unexercised options to purchase shares of Cara common stock will remain effective and outstanding. Any Cara options granted after consummation of the Merger that are not yet vested will be subject to “double-trigger” accelerated vesting upon a termination by Cara without “cause” (and not including death or disability) or resignation for “good reason,” in either case, on or within 12 months following the occurrence of a “change in control” (which will occur upon consumm